Cargando…
Tamoxifen resistance-related ceRNA network for breast cancer
Background: Tamoxifen (TMX) is one of the most widely used drugs to treat breast cancer (BC). However, acquired drug resistance is still a major obstacle to its application, rendering it crucial to explore the mechanisms of TMX resistance in BC. This aims of this study were to identify the mechanism...
Autores principales: | Qiao, Zipeng, Xing, Yu, Zhang, Qingquan, Tang, Yongjun, Feng, Ruifa, Pang, Weiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733938/ https://www.ncbi.nlm.nih.gov/pubmed/36506097 http://dx.doi.org/10.3389/fcell.2022.1023079 |
Ejemplares similares
-
The Functional Characterization of Epigenetically Related lncRNAs Involved in Dysregulated CeRNA–CeRNA Networks Across Eight Cancer Types
por: Xu, Dahua, et al.
Publicado: (2021) -
Characterization of Dysregulated lncRNA-Associated ceRNA Network Reveals Novel lncRNAs With ceRNA Activity as Epigenetic Diagnostic Biomarkers for Osteoporosis Risk
por: Zhang, Meijie, et al.
Publicado: (2020) -
Mechanism of circADD2 as ceRNA in Childhood Acute Lymphoblastic Leukemia
por: Zhu, Yuting, et al.
Publicado: (2021) -
Susceptibility Modules and Genes in Hypertrophic Cardiomyopathy by WGCNA and ceRNA Network Analysis
por: Sun, Yifan, et al.
Publicado: (2022) -
Comprehensive analysis of GINS subunits prognostic value and ceRNA network in sarcoma
por: Zhou, Chuqiao, et al.
Publicado: (2022)